Xeris Pharmaceuticals Inc. (XERS) Files $250M Mixed Shelf

Xeris Pharmaceuticals Inc. (NASDAQ: XERS) has filed $250,000,000 mixed shelf of:

Common Stock
Preferred Stock
Debt Securities
Warrants
Units

You May Also Be Interested In

• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• Raymond James sees positive earnings trends across market caps
• Cinema United urges California to resolve Paramount-Warner merger